COFEPRIS Medical Device Sanitary Registration Query System 2026

1. Key takeaways

Mexico launched the medical device sanitary registration query system (Visor de Registros Sanitarios de Dispositivos Médicos) on 2026-08-20, as announced in COFEPRIS press release 21/2026. The system centralises the display of valid sanitary registrations that comply with the law and is open to the public and to healthcare institutions. It is deployed in two phases, with the first phase publishing initial data and the second phase planned as a continuously updated platform whose start date is still pending verification. For manufacturers, the practical effect is immediate and unavoidable: from the launch date onward, their Mexican registration status is publicly searchable, and anyone in the market can verify it directly against the official record. That shift moves registration accuracy from an administrative detail to a commercial asset: errors on the screen are errors seen by every procurement team that searches the product.

• The query system went live on 2026-08-20 under COFEPRIS press release 21/2026.
• Only registrations that comply with the law are included; what cannot be found is treated by the market as unregistered.
• Registration holders had a two-week window in the first phase to submit observations on the accuracy of their data.
• The second phase converts the platform into a dynamically updated system once data verification and correction are complete.
• The tool doubles as competitive intelligence and as a supply chain compliance screen, and it rewards companies that check their own entries first.

2. Legal basis

The system was not created by a new substantive obligation but by an administrative launch that operationalises existing registration data, so the legal content lies mainly in the phased deployment and in the correction rights granted to holders during the first phase. The phases, the observation window, and the reference path are set out in the table below, and each item should be checked against the official announcement when planning a correction.

3. Expert insights

Insight one: public search changes the visibility of compliance. Before the launch, confirming whether a product was legally registered in Mexico often depended on paper documents or informal channels. With the system live, hospitals, distributors, and manufacturers all have an official online verification channel, and the answer a counterparty finds there is the one that will govern the commercial decision. Periodic self-searching is therefore now part of routine compliance housekeeping rather than an optional extra.

Insight two: only legally valid registrations are included. COFEPRIS emphasises that only registrations complying with the law are incorporated into the system. Being findable means compliant and valid; not being findable will be read by the market directly as unregistered, regardless of the actual paperwork that may exist elsewhere. Distribution agreements should be reviewed with this in mind, because partners will rely on the screen rather than on certificates sent by email.

Insight three: a two-week verification window was given. The first phase allowed registration holders to submit observations on the accuracy of their own registration information within two weeks. Once that window closed, erroneous information remained publicly visible until the second phase corrects it, which is precisely why the launch date and the window needed to be monitored from day one. Holders who missed the window should keep documentary evidence of the correct data ready for the second-phase mechanism.

Insight four: the system is simultaneously a competitive intelligence and supply chain compliance tool. Companies can query the registration status of competing products, and they can also verify the qualifications a distributor claims to hold. On the purchasing side, the system can be used for supplier admission screening, which turns public registration data into an operating input rather than a mere transparency gesture. The same search also reveals whether a competitor’s listed coverage overlaps a planned launch.

Insight five: the launch belongs to the same line as the digitalisation reforms. The query system sits alongside DIGIPRiS, the simplified pathway, and the extension of renewal terms as parts of COFEPRIS’s recent reform package, and the direction of travel is consistent across them: faster market access, longer certificates, and more transparent data. Companies planning multi-year Mexico programmes should assume that further digitalisation steps will follow in the same sequence of announcements.

4. Practical recommendations

• Search the records of your own products in the system immediately, and verify the name, holder, validity period, and product information against your internal records rather than against memory.
• Submit corrections within the observation window; after it closes, follow the second-phase update mechanism for any remaining errors and keep the correspondence trail for the file.
• Include whether a product can be retrieved in the query system as an item on the distributor qualification checklist, alongside the usual licence and quality documentation.
• Use the system to monitor the registration status and product coverage of competitors as a reference input for market entry decisions, and refresh that review on a defined cycle.
• Where registration information has changed, re-check after the change whether the system display has been synchronised, and raise a correction promptly if the old data still appears.

5. Verification checklist

• □ Own product records have been searched in the system
• □ Name, holder, validity period, and product information have been verified
• □ Observations were submitted within the two-week window where applicable
• □ System search results are included in distributor qualification review
• □ Post-change system display has been re-checked for synchronisation

Regulatory information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Mexican market. Our team manages COFEPRIS registrations and equivalence (equivalencia) reviews, coordinates third-party authorised centre routes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com